Christi Shaw at JP Morgan 2019. Jeff Rumans for Endpoints News
July 11, 2019 11:33 AM EDTUpdated 12:50 PM
People

Eli Lil­ly's Christi Shaw bows out of top post at the Bio-Med­i­cines unit

John Carroll

Editor & Founder

Less than 3 years af­ter Eli Lil­ly CEO David Ricks re­cruit­ed No­var­tis vet Christi Shaw to run their big Bio-Med­i­cines busi­ness, she’s out.

In a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times